| 2021-08-11 | -46.0% | legal | SEC EDGAR | GOCO 8-K: 2.02 and (SEC Filing) |
| 2022-03-02 | -44.5% | legal | SEC EDGAR | GOCO 8-K: 2.02, 5.02 (SEC Filing) |
| 2023-05-08 | +32.7% | legal | SEC EDGAR | GOCO 8-K: 2.02 and (SEC Filing) |
| 2022-08-15 | -32.1% | legal | SEC EDGAR | GOCO 8-K: 2.02 and (SEC Filing) |
| 2022-08-15 | -32.1% | legal | SEC EDGAR | GOCO 8-K: 1.01 and (SEC Filing) |
| 2024-08-07 | -25.8% | earnings | Seeking Alpha | GoHealth Q2 Earnings Preview |
| 2025-11-13 | -24.6% | news | Seeking Alpha | GoHealth outlines disciplined strategy and industry consolidation focus amid Medicare Advantage market shifts |
| 2025-11-13 | -24.6% | earnings | Seeking Alpha | GoHealth, Inc. (GOCO) Q3 2025 Earnings Call Transcript |
| 2025-11-13 | -24.6% | earnings | Seeking Alpha | GoHealth GAAP EPS of -$11.80 misses by $9.81, revenue of $34.19M misses by $68.16M |
| 2025-11-13 | -24.6% | legal | SEC EDGAR | GOCO 8-K: 2.02 and (SEC Filing) |
| 2025-11-13 | -24.6% | earnings | Yahoo Finance | GoHealth Inc (GOCO) Q3 2025 Earnings Call Highlights: Strategic Shifts and Market Challenges - Yahoo Finance |
| 2025-11-13 | -24.6% | earnings | TradingView | GoHealth, Inc. Q3 2025 Financial Results - TradingView |
| 2024-08-08 | -24.1% | earnings | Seeking Alpha | GoHealth, Inc. 2024 Q2 - Results - Earnings Call Presentation |
| 2024-08-08 | -24.1% | earnings | Seeking Alpha | GoHealth, Inc. (GOCO) Q2 2024 Earnings Call Transcript |
| 2024-08-08 | -24.1% | earnings | Seeking Alpha | GoHealth misses Q2 estimates |
| 2024-08-08 | -24.1% | legal | SEC EDGAR | GOCO 8-K: 2.02 and (SEC Filing) |
| 2022-11-10 | -23.2% | legal | SEC EDGAR | GOCO 8-K: 2.02 and (SEC Filing) |
| 2025-11-12 | -22.2% | earnings | Seeking Alpha | GoHealth Q3 Earnings Preview |
| 2023-03-17 | -21.9% | legal | SEC EDGAR | GOCO 8-K: 1.01 and (SEC Filing) |
| 2022-12-07 | +21.7% | legal | SEC EDGAR | GOCO 8-K: 8.01 (SEC Filing) |
| 2025-02-27 | -21.2% | earnings | Seeking Alpha | GoHealth, Inc. (GOCO) Q4 2024 Earnings Call Transcript |
| 2025-02-27 | -21.2% | earnings | Seeking Alpha | GoHealth, Inc. 2024 Q4 - Results - Earnings Call Presentation |
| 2025-02-27 | -21.2% | earnings | Seeking Alpha | GoHealth GAAP EPS of $1.56 beats by $0.59, revenue of $389.13M beats by $62.57M |
| 2025-02-27 | -21.2% | legal | SEC EDGAR | GOCO 8-K: 2.02 and (SEC Filing) |
| 2023-03-16 | -20.1% | legal | SEC EDGAR | GOCO 8-K: 2.02 and (SEC Filing) |
| 2022-03-15 | +19.3% | legal | SEC EDGAR | GOCO 8-K: 2.02 and (SEC Filing) |
| 2025-05-01 | -18.5% | news | Seeking Alpha | Aetna, Humana accused of discrimination in Medicare Advantage plan enrollment |
| 2026-03-31 | -16.8% | earnings | Zacks | GoHealth (GOCO) Reports Q4 Loss, Misses Revenue Estimates |
| 2026-03-31 | -16.8% | earnings | Associated Press | GoHealth: Q4 Earnings Snapshot |
| 2026-03-31 | -16.8% | news | GlobeNewswire | GoHealth Prioritizes Consumer Fit, Renewal Economics and Cash Discipline While Continuing Leadership in Special Needs Plans; Reports Full Year 2025 Results |
| 2026-03-31 | -16.8% | earnings | Seeking Alpha | GoHealth GAAP EPS of -$20.17 misses by $0.08, revenue of $361.84M misses by $76M |
| 2026-03-31 | -16.8% | legal | SEC EDGAR | GOCO 8-K: 2.02 (SEC Filing) |
| 2026-03-31 | -16.8% | earnings | Quiver Quantitative | GoHealth Inc. (GOCO) Stock Falls on Q4 2025 Earnings - Quiver Quantitative |
| 2026-03-31 | -16.8% | earnings | Yahoo Finance | GoHealth (GOCO) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance |
| 2026-03-31 | -16.8% | news | Quiver Quantitative | GOCO | GoHealth, Inc. Class A Financials - Income Statement - Quiver Quantitative |
| 2026-03-31 | -16.8% | news | Stock Titan | GoHealth pulls back on Medicare Advantage, bets on retention and AI - Stock Titan |
| 2026-03-31 | -16.8% | earnings | Stock Titan | Steep revenue decline drives 2025 loss at GoHealth (NASDAQ: GOCO) - Stock Titan |
| 2022-01-28 | +16.2% | legal | SEC EDGAR | GOCO 8-K: 5.02 (SEC Filing) |
| 2024-11-06 | -15.1% | earnings | Seeking Alpha | GoHealth Q3 Earnings Preview |
| 2026-03-20 | +14.9% | news | TipRanks | GoHealth Faces Nasdaq Noncompliance, Delisting Risk Looms - TipRanks |
| 2026-03-20 | +14.9% | news | Stock Titan | GoHealth (NASDAQ: GOCO) warned over Nasdaq Global Market compliance - Stock Titan |
| 2022-05-10 | +12.4% | legal | SEC EDGAR | GOCO 8-K: 2.02 and (SEC Filing) |
| 2023-01-09 | +12.3% | legal | SEC EDGAR | GOCO 8-K: 5.02 (SEC Filing) |
| 2025-08-07 | -12.1% | legal | SEC EDGAR | GOCO 8-K: 1.01, 2.02, 2.03, 3.02, 5.02 (SEC Filing) |
| 2024-03-14 | -11.8% | legal | SEC EDGAR | GOCO 8-K: 2.02 and (SEC Filing) |
| 2024-03-14 | -11.8% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2026-04-15 | +11.1% | news | Simply Wall St. | How The GoHealth (GOCO) Narrative Is Shifting After Target Reset And Nasdaq Compliance Risks |
| 2022-03-16 | +10.7% | legal | SEC EDGAR | GOCO 8-K: 1.01 and (SEC Filing) |
| 2026-02-05 | -10.2% | earnings | Simply Wall St. | Looking At The Narrative For GoHealth (GOCO) After Q3 Reset And Carrier Shakeup |
| 2026-03-26 | -9.7% | expansion | TMX Newsfile | Go Metals Announces Mutual Termination of Option Agreement |
| 2025-11-06 | -9.6% | news | Yahoo Finance | GoHealth, Inc. (NASDAQ:GOCO) has caught the attention of institutional investors who hold a sizeable 33% stake - Yahoo Finance |
| 2025-02-25 | +8.7% | news | Yahoo Finance | Why GoHealth, Inc. (GOCO) Is Skyrocketing So Far In 2025 - Yahoo Finance |
| 2024-05-09 | -8.7% | legal | SEC EDGAR | GOCO 8-K: 2.02 and (SEC Filing) |
| 2023-01-19 | -8.6% | legal | SEC EDGAR | GOCO 8-K: 2.02 and (SEC Filing) |
| 2025-05-13 | -8.5% | earnings | Seeking Alpha | GoHealth outlines ramp-up of GoHealth Protect to boost full-year 2025 results amid 19% revenue growth |
| 2025-05-13 | -8.5% | earnings | Seeking Alpha | GoHealth, Inc. (GOCO) Q1 2025 Earnings Call Transcript |
| 2025-05-13 | -8.5% | earnings | Seeking Alpha | GoHealth, Inc. 2025 Q1 - Results - Earnings Call Presentation |
| 2025-05-13 | -8.5% | earnings | Seeking Alpha | GoHealth GAAP EPS of -$0.52 misses by $0.19, revenue of $221M misses by $4.91M |
| 2025-05-13 | -8.5% | legal | SEC EDGAR | GOCO 8-K: 2.02 and (SEC Filing) |
| 2021-12-22 | +8.2% | legal | SEC EDGAR | GOCO 8-K: 5.02 (SEC Filing) |
| 2025-05-28 | -8.2% | legal | Seeking Alpha | Regulatory Winds And Execution Catalyze GoHealth's Upside |
| 2022-06-08 | -8.2% | legal | SEC EDGAR | GOCO 8-K: 5.02 (SEC Filing) |
| 2025-02-26 | -7.9% | earnings | Seeking Alpha | GoHealth Q4 Earnings Preview |
| 2024-11-07 | -7.8% | earnings | Seeking Alpha | GoHealth GAAP EPS of $0.46, revenue of $118.3M beats by $11.38M |
| 2024-11-07 | -7.8% | legal | SEC EDGAR | GOCO 8-K: 2.02 and (SEC Filing) |
| 2024-11-16 | -7.3% | news | Seeking Alpha | GoHealth: Smart Moves Are Paying Off |
| 2024-07-10 | +7.2% | legal | SEC EDGAR | GOCO 8-K: 5.02, 7.01 (SEC Filing) |
| 2023-08-10 | +6.8% | legal | SEC EDGAR | GOCO 8-K: 2.02 and (SEC Filing) |
| 2021-09-22 | -6.6% | analyst | eToro | GoHealth Inc (GOCO) Stock Price, News & Analyst Forecast - eToro |
| 2022-09-05 | -6.2% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for GoHealth (GOCO) - Zacks Investment Research |
| 2025-11-14 | -6.2% | earnings | Seeking Alpha | GoHealth, Inc. 2025 Q3 - Results - Earnings Call Presentation |
| 2025-11-14 | -6.2% | legal | TradingView | GoHealth, Inc. SEC 10-Q Report - TradingView |
| 2025-11-17 | -5.9% | earnings | Stock Titan | GoHealth (NASDAQ: GOCO) Q3 Revenue Down 71% on Medicare Advantage Pullback - Stock Titan |
| 2022-09-15 | +5.1% | legal | SEC EDGAR | GOCO 8-K: 5.02 (SEC Filing) |
| 2022-04-08 | -5.1% | legal | SEC EDGAR | GOCO 8-K: 5.02 (SEC Filing) |
| 2025-05-12 | -5.1% | earnings | Seeking Alpha | GoHealth Q1 Earnings Preview |
| 2025-05-12 | -5.1% | legal | Business Wire | Securities Fraud Investigation Into GoHealth, Inc. (GOCO) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm - Business Wire |
| 2022-07-14 | -4.9% | legal | SEC EDGAR | GOCO 8-K: 5.02 (SEC Filing) |
| 2021-11-10 | +4.7% | legal | SEC EDGAR | GOCO 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-08-19 | -4.3% | legal | SEC EDGAR | GOCO 8-K: 5.02 and (SEC Filing) |
| 2026-04-16 | +4.0% | earnings | TMX Newsfile | Stonegate Capital Partners Updates Coverage on GoHealth Inc. (GOCO) 4Q25 |
| 2026-04-16 | +4.0% | news | Seeking Alpha | GoHealth reports FY results |
| 2026-04-16 | +4.0% | earnings | Stock Titan | GoHealth puts retention first as a $925M commission asset stays in focus - Stock Titan |
| 2025-05-08 | -4.0% | news | Intellectia AI | GOCO Forecast — Price Prediction for 2026. Should I Buy GOCO? - Intellectia AI |
| 2026-04-23 | -4.0% | earnings | UBND thành phố Hải Phòng | GoHealth (GOCO) Stock Risk | Q4 2025: EPS Misses Estimates - Macro Risk - UBND thành phố Hải Phòng |
| 2026-04-23 | -4.0% | earnings | Cổng thông tin điện tử tỉnh Tây Ninh | GoHealth (GOCO) Stock: Market Pressure Analysis | Q4 2025: Earnings Fall Short - Geographic Diversification - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2021-12-10 | -3.7% | legal | SEC EDGAR | GOCO 8-K: 5.02 (SEC Filing) |
| 2024-09-04 | -3.5% | M&A | Seeking Alpha | GoHealth to acquire medicare insurance marketplace e-TeleQuote Insurance |
| 2024-11-09 | -3.2% | earnings | Seeking Alpha | GoHealth, Inc. 2024 Q3 - Results - Earnings Call Presentation |
| 2024-11-09 | -3.2% | earnings | Seeking Alpha | GoHealth, Inc. (GOCO) Q3 2024 Earnings Call Transcript |
| 2025-04-07 | +3.1% | legal | SEC EDGAR | GOCO 8-K: 5.02 and (SEC Filing) |
| 2025-04-07 | +3.1% | expansion | TipRanks | GoHealth Extends CEO Vijay Kotte’s Contract and Compensation - TipRanks |
| 2026-04-22 | -3.1% | earnings | Cổng thông tin điện tử tỉnh Lào Cai | GoHealth (GOCO) Stock: Market Pressure Analysis | Q4 2025: Earnings Fall Short - Most Watched Stocks - Cổng thông tin điện tử tỉnh Lào Cai |
| 2023-06-06 | -2.7% | legal | SEC EDGAR | GOCO 8-K: 5.02 (SEC Filing) |
| 2024-10-10 | -2.4% | executive | Seeking Alpha | GoHealth appoints Brendan Shanahan as CFO |
| 2024-10-10 | -2.4% | legal | SEC EDGAR | GOCO 8-K: 5.02, 7.01 (SEC Filing) |
| 2021-10-20 | +2.3% | legal | SEC EDGAR | GOCO 8-K: 5.02 (SEC Filing) |
| 2021-11-09 | +2.2% | legal | SEC EDGAR | GOCO 8-K: 2.02 and (SEC Filing) |
| 2022-04-29 | +2.0% | legal | SEC EDGAR | GOCO 8-K: 5.02 (SEC Filing) |
| 2024-06-21 | -2.0% | legal | SEC EDGAR | GOCO 8-K: 5.02 (SEC Filing) |
| 2021-08-30 | +1.8% | legal | SEC EDGAR | GOCO 8-K: 5.02 (SEC Filing) |
| 2021-05-12 | -1.7% | legal | SEC EDGAR | GOCO 8-K: 2.02 and (SEC Filing) |
| 2023-11-09 | +1.5% | legal | SEC EDGAR | GOCO 8-K: 2.02 and (SEC Filing) |
| 2026-02-28 | -1.5% | news | Intellectia AI | GOCO Technical Analysis & Stock Price Forecast - Intellectia AI |
| 2022-05-27 | +1.5% | legal | SEC EDGAR | GOCO 8-K: 3.01, 5.02and5.07 (SEC Filing) |
| 2025-10-13 | +1.1% | news | simplywall.st | In the wake of GoHealth, Inc.'s (NASDAQ:GOCO) latest US$7.8m market cap drop, institutional owners may be forced to take severe actions - simplywall.st |
| 2021-06-14 | +0.8% | legal | SEC EDGAR | GOCO 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-06-30 | +0.8% | legal | SEC EDGAR | GOCO 8-K: 1.01, 2.03, 7.01 (SEC Filing) |
| 2024-06-04 | -0.5% | legal | SEC EDGAR | GOCO 8-K: 5.02, 7.01 (SEC Filing) |
| 2021-08-08 | -0.5% | earnings | Zacks Investment Research | What date does GoHealth's (GOCO) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research |
| 2022-09-26 | -0.5% | legal | SEC EDGAR | GOCO 8-K: 1.01, 3.02, 3.03, 5.03, 7.01 (SEC Filing) |
| 2024-04-01 | +0.4% | analyst | TradingView | GOCO Forecast — Price Target — Prediction for 2027 - TradingView |
| 2024-06-25 | -0.3% | legal | SEC EDGAR | GOCO 8-K: 5.02 (SEC Filing) |
| 2026-04-13 | +0.2% | news | GlobeNewswire | GoHealth, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire |
| 2025-08-08 | +0.1% | earnings | Seeking Alpha | GoHealth, Inc. (GOCO) Q2 2025 Earnings Call Transcript |